Human-to-dog transmission of SARS-CoV-2, Colombia.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
12 05 2022
12 05 2022
Historique:
received:
17
08
2021
accepted:
29
04
2022
entrez:
13
5
2022
pubmed:
14
5
2022
medline:
18
5
2022
Statut:
epublish
Résumé
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of the current COVID-19 pandemic, has evolved to have a wide range of hosts, including non-human primates, wild and domestic animals. The ACE2 protein has a high level of conservation and is the common receptor invertebrate species for a viral infection to occur; this receptor could give rise to anthroponotic events. This article describes the first event of symptomatic transmission in Latin America from a human to a dog by the B.1.625 lineage of SARS-CoV-2. We found 21 shared mutations in the complete genomes of viral sequences from owners and dogs. Further phylogenetic and molecular analysis showed that 100% co-localization of the clade helps to understand human-animal transmission. Prediction of the Spike protein structure of the sequenced virus and docking analyzes showed that the E484K mutation in the receptor-binding domain (RBD) could contribute to the viral affinity of dACE2. Therefore, close contact between SARS-CoV-2-infected humans and pets should be avoided to prevent the emergence of novel mutations of public health importance from anthroponotic events.
Identifiants
pubmed: 35551247
doi: 10.1038/s41598-022-11847-9
pii: 10.1038/s41598-022-11847-9
pmc: PMC9097567
doi:
Substances chimiques
Spike Glycoprotein, Coronavirus
0
spike protein, SARS-CoV-2
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
7880Informations de copyright
© 2022. The Author(s).
Références
Int J Mol Sci. 2016 Jan 26;17(2):
pubmed: 26821017
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W665-7
pubmed: 15215472
Proc Natl Acad Sci U S A. 2021 Sep 7;118(36):
pubmed: 34417349
MMWR Suppl. 2012 Jan 6;61(1):1-102
pubmed: 22217667
Mol Biol Evol. 2018 Feb 1;35(2):518-522
pubmed: 29077904
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
Cell. 2021 May 13;184(10):2595-2604.e13
pubmed: 33891875
Biochem Biophys Res Commun. 2020 May 21;526(1):165-169
pubmed: 32201080
Nat Commun. 2020 Nov 26;11(1):6013
pubmed: 33243994
Science. 2021 Jan 8;371(6525):172-177
pubmed: 33172935
Bioinformatics. 2019 Aug 15;35(16):2856-2858
pubmed: 30615063
Rev Med Virol. 2021 Nov;31(6):e2231
pubmed: 33724631
ACS Med Chem Lett. 2020 Aug 17;11(9):1667-1670
pubmed: 32934770
Nature. 2021 May;593(7857):142-146
pubmed: 33780970
Lancet Microbe. 2021 Jul;2(7):e283-e284
pubmed: 33846703
Nat Med. 2021 Apr;27(4):622-625
pubmed: 33654292
Nature. 2020 Oct;586(7831):776-778
pubmed: 32408337
Sci Immunol. 2020 Jun 11;5(48):
pubmed: 32527802
Science. 2021 Aug 6;373(6555):
pubmed: 34168071
Mol Med Rep. 2020 Jun;21(6):2293-2295
pubmed: 32236594
Transbound Emerg Dis. 2021 Jul;68(4):1767-1773
pubmed: 33191649
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Science. 2021 Feb 12;371(6530):708-712
pubmed: 33419936
Nat Commun. 2021 Jul 7;12(1):4195
pubmed: 34234119
Nucleic Acids Res. 2021 Jul 2;49(W1):W293-W296
pubmed: 33885785
Nature. 2020 Nov;587(7834):340-341
pubmed: 33188367
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Bioinformatics. 2012 Dec 1;28(23):3144-6
pubmed: 23023983
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
Nat Med. 2021 Jul;27(7):1230-1238
pubmed: 34035535
Proc Natl Acad Sci U S A. 2020 Oct 20;117(42):26382-26388
pubmed: 32994343
Nat Methods. 2017 Jun;14(6):587-589
pubmed: 28481363
PLoS Biol. 2020 Jul 14;18(7):e3000410
pubmed: 32663219
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
Vet Res. 2021 Feb 15;52(1):22
pubmed: 33588935
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Vacunas. 2020 Jan-Jun;21(1):17-22
pubmed: 32565763